SEC Form 4 · accession 0001209191-17-023212
SPECTRUM PHARMACEUTICALS INC · SPPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt A Gustafson
Officer — EVP & Chief Financial Officer
Period of report
Mar 25, 2017
Accepted (ET)
Mar 28, 2017 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Mar 25, 2017 | F | 1,410 | $6.61 | D | 135,338 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted shares withheld by Spectrum to satisfy Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.